Neuroprotection via inhibition of nitric oxide synthase by bis(7)-tacrine

被引:26
作者
Li, WM [1 ]
Lee, NTK
Fu, HJ
Kan, KKW
Pang, YP
Li, MT
Tsim, KWK
Li, XY
Han, YF
机构
[1] Hong Kong Univ Sci & Technol, Dept Biochem, Hong Kong, Hong Kong, Peoples R China
[2] Hong Kong Univ Sci & Technol, Dept Biol, Hong Kong, Hong Kong, Peoples R China
[3] Hong Kong Univ Sci & Technol, Dept Chem, Hong Kong, Hong Kong, Peoples R China
[4] Mayo Fdn Med Educ & Res, Rochester, MN USA
[5] Sun Yat Sen Univ, Zhongshan Med Coll, Dept Pharmacol, Guangzhou, Peoples R China
[6] Sun Yat Sen Univ, Zhongshan Med Coll, Proteom Lab, Guangzhou, Peoples R China
关键词
bis(7)-tacrine; neuroprotection; nitric oxide synthase;
D O I
10.1097/01.wnr.0000209014.09094.72
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Here we report that bis(7)-tacrine, a novel acetylcholinesterase inhibitor, exerts neuroprotective effects by inhibition of nitric oxide synthase. In cortical neurons at 12 days in vitro, bis(7)-tacrine concentration-dependently reduced cell death induced by glutamate, beta-amyloid and (L)-arginine, but not by nitric sodium nitroprusside. N-monomethyl-L-arginine, a nitric oxide synthase inhibitor, also prevented the former three types but not the last type of the cytotoxicity; however, nitric oxide scavengers blocked all of these insults, indicating that nitric oxide mediated these neuronal injuries. Furthermore, with nitric oxide synthase activity assays, it was found that bis(7)-tacrine not only suppressed the activation of nitric oxide synthase caused by glutamate in cortical neurons, but also directly inhibited the activity of nitric oxide synthase in vitro. NeuroReport 17:471-474 (c) 2006 Lippincott Williams & Wilkins.
引用
收藏
页码:471 / 474
页数:4
相关论文
共 18 条
[1]   Treatment of ischemic brain damage by perturbing NMDA receptor-PSD-95 protein interactions [J].
Aarts, M ;
Liu, YT ;
Liu, LD ;
Besshoh, S ;
Arundine, M ;
Gurd, JW ;
Wang, YT ;
Salter, MW ;
Tymianski, M .
SCIENCE, 2002, 298 (5594) :846-850
[2]   Nitric oxide synthases: structure, function and inhibition [J].
Alderton, WK ;
Cooper, CE ;
Knowles, RG .
BIOCHEMICAL JOURNAL, 2001, 357 (03) :593-615
[3]   Nitric oxide, cell signaling and cell death [J].
Blaise, GA ;
Gauvin, D ;
Gangal, M ;
Authier, S .
TOXICOLOGY, 2005, 208 (02) :177-192
[4]   Nitric oxide neurotoxicity in neurodegenerative diseases [J].
Boje, KMK .
FRONTIERS IN BIOSCIENCE-LANDMARK, 2004, 9 :763-776
[5]   Structures of nitric oxide synthase isoforms complexed with the inhibitor AR-R17477 suggest a rational basis for specificity and inhibitor design [J].
Fedorov, R ;
Vasan, R ;
Ghosh, DK ;
Schlichting, I .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (16) :5892-5897
[6]   Protection against ischemic injury in primary cultured astrocytes of mouse cerebral cortex by bis(7)-tacrine, a novel anti-Alzheimer's agent [J].
Han, YF ;
Wu, DC ;
Xiao, XA ;
Chen, PMY ;
Chung, W ;
Lee, NTK ;
Pang, YP ;
Carlier, PR .
NEUROSCIENCE LETTERS, 2000, 288 (02) :95-98
[7]   Amyloid β-induced changes in nitric oxide production and mitochondrial activity lead to apoptosis [J].
Keil, U ;
Bonert, A ;
Marques, CA ;
Scherping, I ;
Weyermann, JR ;
Strosznajder, JB ;
Müller-Spahn, F ;
Haass, C ;
Czech, C ;
Pradier, L ;
Müller, WE ;
Eckert, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (48) :50310-50320
[8]   Novel dimeric acetylcholinesterase inhibitor bis(7)-tacrine, but not donepezil, prevents glutamate-induced neuronal apoptosis by blocking N-methyl-D-aspartate receptors [J].
Li, WM ;
Pi, RB ;
Chan, HHN ;
Fu, HJ ;
Lee, NTK ;
Tsang, HW ;
Pu, YM ;
Chang, DC ;
Li, CY ;
Luo, JL ;
Xiong, KM ;
Li, ZW ;
Xue, H ;
Carlier, PR ;
Pang, YP ;
Tsim, KWK ;
Li, MT ;
Han, YF .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (18) :18179-18188
[9]   Bis(7)-tacrine, a novel acetylcholinesterase inhibitor, reverses AF64A-induced deficits in navigational memory in rats [J].
Liu, J ;
Ho, WL ;
Lee, NTK ;
Carlier, PR ;
Pang, YP ;
Han, YF .
NEUROSCIENCE LETTERS, 2000, 282 (03) :165-168
[10]   Highly potent, selective, and low cost bis-tetrahydroaminacrine inhibitors of acetylcholinesterase - Steps toward novel drugs for treating Alzheimer's disease [J].
Pang, YP ;
Quiram, P ;
Jelacic, T ;
Hong, F ;
Brimijoin, S .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (39) :23646-23649